CDC Blog Post Highlights Burkina Faso’s Experience Implementing Meningitis Vaccine Campaign

CDC’s “Our Global Voices”: Proud to Protect Burkinabè from Meningitis
Isaïe Medah, physician and director general of public health in Burkina Faso, discusses the implementation of the meningococcal serogroup A conjugate vaccine (MenAfriVac, MACV) in Burkina Faso. Medah writes, “I believe we should continue developing new effective meningitis vaccines to defeat the remaining causes of epidemic meningitis. It is my hope that someday we will achieve the dream of a meningitis-free Africa” (4/20).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.